Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct 30:2:40.
doi: 10.1186/1748-717X-2-40.

Regional radiotherapy versus an axillary lymph node dissection after lumpectomy: a safe alternative for an axillary lymph node dissection in a clinically uninvolved axilla in breast cancer. A case control study with 10 years follow up

Patty H Spruit  1 , Sabine Siesling, Marloes A G Elferink, Ernest J A Vonk, Carel J M Hoekstra
Affiliations

Regional radiotherapy versus an axillary lymph node dissection after lumpectomy: a safe alternative for an axillary lymph node dissection in a clinically uninvolved axilla in breast cancer. A case control study with 10 years follow up

Patty H Spruit et al. Radiat Oncol. .

Abstract

Background: The standard treatment of the axilla in breast cancer used to be an axillary lymph node dissection. An axillary lymph node dissection is known to give substantial risks of morbidity. In recent years the sentinel node biopsy has become common practice. Future randomized study results will determine whether the expected decrease in morbidity can be proven.

Methods: Before the introduction of the sentinel node biopsy, we conducted a study in which 180 women of 50 years and older with T1/T2 cN0 breast cancer were treated with breast conserving therapy. Instead of an axillary lymph node dissection regional radiotherapy was given in combination with tamoxifen (RT-group). The study group was compared with 341 patients, with the same patient and tumour characteristics, treated with an axillary lymph node dissection (S-group).

Results: The treatment groups were comparable, except for age. The RT-group was significantly older than the S-group. The median follow up was 7.2 years. The regional relapse rates were low and equal in both treatment groups, 1.1% in RT-group versus 1.5% in S-group at 5 years. The overall survival was similar; the disease free survival was significant better in the RT-group.

Conclusion: Regional recurrence rates after regional radiotherapy are very low and equal to an axillary lymphnode dissection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall survival by treatment, with numbers of patients at risk at 10 years.
Figure 2
Figure 2
Disease free survival by treatment, with numbers of patients at risk at 10 years.
See this image and copyright information in PMC

References

    1. Chua B, Ung O, Boyages J. Treatment of the axilla in early breast cancer: past, present and future. ANZ J Surg. 2001;71:729–736. doi: 10.1046/j.1445-1433.2001.02271.x. - DOI - PubMed
    1. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet. 1981;152:765–772. - PubMed
    1. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Margolese R, Foster R. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985;312:674–681. - PubMed
    1. Pierquin B, Mazeron JJ, Glaubiger D. Conservative treatment of breast cancer in Europe: report of the Groupe Europeen de Curietherapie. Radiother Oncol. 1986;6:187–198. doi: 10.1016/S0167-8140(86)80153-0. - DOI - PubMed
    1. Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg. 2004;187:69–72. doi: 10.1016/j.amjsurg.2002.12.003. - DOI - PubMed

MeSH terms